Uniparental Trisomy of a Mutated HRAS Proto-Oncogene in Embryonal Rhabdomyosarcoma of a Patient With Costello Syndrome

J Clin Oncol. 2015 May 1;33(13):e62-5. doi: 10.1200/JCO.2013.49.6539. Epub 2014 Mar 17.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Abdominal Neoplasms / chemistry
  • Abdominal Neoplasms / diagnosis
  • Abdominal Neoplasms / genetics*
  • Abdominal Neoplasms / pathology
  • Abdominal Neoplasms / surgery
  • Biomarkers, Tumor / genetics*
  • Chemotherapy, Adjuvant
  • Child, Preschool
  • Chromosomes, Human, Pair 11*
  • Costello Syndrome / diagnosis
  • Costello Syndrome / genetics*
  • DNA Mutational Analysis
  • Female
  • Genetic Predisposition to Disease
  • Genetic Testing / methods
  • Heredity
  • Heterozygote
  • Humans
  • Immunohistochemistry
  • Magnetic Resonance Imaging
  • Mutation*
  • Neoplasm Grading
  • Pedigree
  • Phenotype
  • Predictive Value of Tests
  • Proto-Oncogene Mas
  • Proto-Oncogene Proteins p21(ras) / genetics*
  • Rhabdomyosarcoma, Embryonal / chemistry
  • Rhabdomyosarcoma, Embryonal / diagnosis
  • Rhabdomyosarcoma, Embryonal / genetics*
  • Rhabdomyosarcoma, Embryonal / pathology
  • Rhabdomyosarcoma, Embryonal / surgery
  • Treatment Outcome
  • Trisomy*

Substances

  • Biomarkers, Tumor
  • MAS1 protein, human
  • Proto-Oncogene Mas
  • HRAS protein, human
  • Proto-Oncogene Proteins p21(ras)